NA (ZLTQ)
(Delayed Data from NSDQ)
$56.48 USD
0.00 (0.00%)
Updated Apr 27, 2017 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ZLTQ]
Reports for Purchase
Showing records 1 - 19 ( 19 total )
Industry: Medical - Products
ValuEngine Detailed Valuation Report for ZLTQ
Provider: ValuEngine, Inc
Industry: Medical - Products
We are suspending coverage of ZELTIQ Aesthetics, Inc.
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Comments on Allergan''s acquisition announcement
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
ZLTQ announces preliminary 4Q16 results; initiates FY17 guidance
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Industry: Medical - Products
Review of 2Q16; revising FY16E-FY17E; raising PO to $48
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN M
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Healthcare - MedTech -AAD 2016 conference takeaways
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Industry: Medical - Products
Healthcare - MedTech-Aesthetic Devices - Q4 Earnings Preview
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Industry: Medical - Products
We are initiating coverage on Zeltiq Aesthetics (ZLTQ) with a Neutral rating. - Shares Fairly Valued
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Industry Update: M-A is Finding Aesthetics Attractive
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Industry: Medical - Products
Industry Update: Aesthetic Laser Devices - Q4 earnings preview
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Industry Update: AAD 2014 conference commentary
Provider: Griffin Securities, Inc.
Analyst: AJZENMAN Z
Industry: Medical - Products
Industry: Medical - Products
|